Friday, October 09, 2026 | 05:27 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Medgenome Labs

Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy

The ₹168 crore acquisition of a 70 per cent stake in SN Genelab is expected to strengthen Dr Lal's genomics expertise and broaden its advanced diagnostics portfolio

Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy
Updated On : 25 Sep 2026 | 10:38 PM IST

MedGenome looks to market novel screening test for coronary artery disease

The test calculates one's risk of developing an artery blockage based on the millions of genetic variations in his anatomy

MedGenome looks to market novel screening test for coronary artery disease
Updated On : 12 Aug 2020 | 4:51 PM IST

Diagnostic firm MedGenome completes series C funding round of Rs 2.6 bn

The latest funding will accelerate the company's expansion in the clinical genomic testing market, especially in Tier-II and Tier-III cities

Diagnostic firm MedGenome completes series C funding round of Rs 2.6 bn
Updated On : 05 Mar 2018 | 5:16 PM IST